Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Coeptis Therapeutics (NASDAQ: COEP)
Follow
NASDAQ:COEP
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
COEP
Coeptis Therapeutics
Cogley Brian
/
officer: Chief Financial Officer
01/10/2024
Buy
$0.67
5,000
$3K
30,000
NASDAQ
COEP
Coeptis Therapeutics
DeSilva Tara
/
director
01/12/2024
Buy
$0.58
1,800
$1K
32,266
NASDAQ
COEP
Coeptis Therapeutics
DeSilva Tara
/
director
01/12/2024
Buy
$0.56
466
$261
30,466
NASDAQ
COEP
Coeptis Therapeutics
Yerace Daniel Alexander
/
director, officer: VP of Operations
01/05/2024
Buy
$0.69
10,850
$7K
1.07M
NASDAQ
COEP
Coeptis Therapeutics
Salkind Gene
/
director
01/05/2024
Buy
$0.69
11,600
$8K
284,056
NASDAQ
COEP
Coeptis Therapeutics
Mehalick David
/
director, 10 percent owner, officer: CEO and President
01/08/2024
Buy
$0.66
14,004
$9K
2.78M
NASDAQ
COEP
Coeptis Therapeutics
Mehalick David
/
director, 10 percent owner, officer: CEO and President
01/08/2024
Buy
$0.67
6,000
$4K
2.77M
NASDAQ
COEP
Coeptis Therapeutics
Mehalick David
/
director, 10 percent owner, officer: CEO and President
01/05/2024
Buy
$0.69
5,050
$3K
2.76M
NASDAQ
COEP
Coeptis Therapeutics
Cochran Christopher P.
/
director
01/05/2024
Buy
$0.77
7,000
$5K
37,000
NASDAQ
COEP
Coeptis Therapeutics
Calise Chris
/
director
08/23/2023
Buy
$0.94
2,582
$2K
1.46M
NASDAQ
COEP
Coeptis Therapeutics
Calise Chris
/
director
08/23/2023
Buy
$0.94
9,000
$8K
1.46M
NASDAQ
COEP
Coeptis Therapeutics
Salkind Gene
/
director
08/25/2023
Buy
$0.91
28,638
$26K
28,638
NASDAQ
COEP
Coeptis Therapeutics
Salkind Gene
/
director
08/29/2023
Buy
$1.01
4,006
$4K
4,046
NASDAQ
COEP
Coeptis Therapeutics
Yerace Daniel Alexander
/
officer: VP of Operations
01/27/2023
Buy
$1.60
200,000
$320K
200,000
NASDAQ
COEP
Coeptis Therapeutics
Sheehy Christine Elise
/
officer: CFO and Secretary
01/27/2023
Buy
$1.60
200,000
$320K
200,000
NASDAQ
COEP
Coeptis Therapeutics
Salkind Gene
/
director
01/27/2023
Buy
$1.60
30,000
$48K
30,000
NASDAQ
COEP
Coeptis Therapeutics
Mehalick David
/
officer: CEO and President
01/27/2023
Buy
$1.60
375,000
$600K
375,000
NASDAQ
COEP
Coeptis Therapeutics
Mehalick David
/
officer: CEO and President
01/27/2023
Buy
$1.76
250,000
$440K
250,000
NASDAQ
COEP
Coeptis Therapeutics
DeSilva Tara
/
director
01/27/2023
Buy
$1.60
30,000
$48K
30,000
NASDAQ
COEP
Coeptis Therapeutics
Deschamps Philippe
/
director
01/27/2023
Buy
$1.60
30,000
$48K
30,000
NASDAQ
COEP
Coeptis Therapeutics
Cochran Christopher P.
/
director
01/27/2023
Buy
$1.60
30,000
$48K
30,000
NASDAQ
COEP
Coeptis Therapeutics
Calise Chris
/
director
01/27/2023
Buy
$1.60
30,000
$48K
30,000
NASDAQ
COEP
Coeptis Therapeutics
Bull Horn Holdings Sponsor LLC
/
10 percent owner
10/28/2022
Buy
$11.50
3.00M
$34.500M
3.00M
NASDAQ
COEP
Coeptis Therapeutics
Bull Horn Holdings Sponsor LLC
/
director
10/28/2022
Buy
$1.00
3.00M
$3.000M
3.00M
NASDAQ
COEP
Coeptis Therapeutics
Bull Horn Holdings Sponsor LLC
/
director
10/28/2022
Buy
$1.00
3.00M
$3.000M
3.00M
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.